![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2008 by The National Academy of Sciences of the USA Neuroscience Neuronal activity regulates phosphorylation-dependent surface delivery of G protein-activated inwardly rectifying potassium channels Department of Physiology, Howard Hughes Medical Institute, University of California, San Francisco, CA 94158 1To whom correspondence should be addressed. E-mail: lily.jan/at/ucsf.edu Contributed by Lily Yeh Jan, November 17, 2008 .Author contributions: H.J.C. designed research; H.J.C., X.Q., and M.E. performed research; H.J.C. and X.Q. analyzed data; Y.N.J. and L.Y.J. contributed new reagents/analytic tools; and H.J.C. wrote the paper. Received October 25, 2008. Freely available online through the PNAS open access option. Abstract G protein-activated inwardly rectifying K+ (GIRK) channels regulate neuronal excitability by mediating inhibitory effects of G protein-coupled receptors for neurotransmitters and neuromodulators. Notwithstanding many studies reporting modulation of GIRK channel function, whether neuronal activity regulates GIRK channel trafficking remains an open question. Here we report that NMDA receptor activation in cultured dissociated hippocampal neurons elevates surface expression of the GIRK channel subunits GIRK1 and GIRK2 in the soma, dendrites, and dendritic spines within 15 min. This activity-induced increase in GIRK surface expression requires protein phosphatase-1-mediated dephosphorylation of a serine residue (Ser-9) preceding the GIRK2 Val-13/Leu-14 (VL) internalization motif, thereby promoting channel recycling. Because activation of GIRK channels hyperpolarizes neuronal membranes, the NMDA receptor-induced regulation of GIRK channel trafficking may represent a dynamic adjustment of neuronal excitability in response to inhibitory neurotransmitters and/or neuromodulators. Keywords: GIRK, NMDA receptor, trafficking, protein phosphatase-1, dendrites G protein-activated inwardly rectifying K+ (GIRK) channels belong to the Kir3.x subfamily of inwardly rectifying potassium channels, with each subunit containing 2 transmembrane segments and cytoplasmic N- and C-terminal domains (1). They regulate neuronal excitability in response to neurotransmitters and neuromodulators that activate G protein-coupled receptors (GPCRs) coupled to pertussis toxin-sensitive Gi/o proteins, inducing the exchange of GDP for GTP on the Gα and dissociation of Gα-GTP from Gβγ (1). GIRK channel activation by direct binding of Gβγ causes hyperpolarization, thus reducing neuronal excitability (1). GIRK channels are also modulated by intracellular Na+, Mg2+, phosphatidylinositol 4,5-bisphosphate, Gαi, and regulators of G protein signaling (2). Neuronal GIRK channels in the central nervous system are mostly heterotetramers of GIRK1 and GIRK2 subunits, whereas midbrain dopaminergic neurons express homomeric GIRK2 channels (1). GIRK channels reside predominantly in the soma and dendrites of pyramidal neurons (1), where their current (3, 4) dampens the effects of excitatory synaptic input (5, 6). They also mediate slow inhibitory postsynaptic current upon GABAB receptor activation and account for the hyperpolarization induced by adenosine and serotonin receptors (7). Underscoring the physiologic importance of GIRK channels, mice lacking GIRK2 display sporadic seizures, increased susceptibility to convulsant agents, and hyperactivity, as well as abnormality in cocaine self-administration, pain threshold, response to analgesics including opioids, and sensitivity to ethanol's motivational effects (8). Dynamic regulation of GIRK channel number affords a powerful way to modulate neuronal activity. Because GIRK1 (9) and GIRK2 (10) reside in the dendrites and dendritic spines that harbor the majority of the excitatory synapses, we wondered whether activation of glutamate receptors would regulate GIRK channel density. In this study we found that activation of NMDA receptors (NMDAR) in cultured hippocampal neurons increased surface expression of GIRK1 and GIRK2 subunits in the soma, dendrites, and some spines by stimulating protein phosphatase-1 (PP1)-dependent dephosphorylation of Ser-9 preceding the GIRK2 Val-13/Leu-14 (VL) internalization signal, thereby enhancing channel delivery from recycling endosomes. Our findings of activity-dependent phosphorylation and trafficking of GIRK channels reveal a novel mechanism for dynamic modulation of neuronal excitability. Results Neuronal Activity Increases Surface Expression of Endogenous GIRK Channels. The proximity of GIRK channels to the synapses (9, 10) (Fig. 1
Because functional extrasynaptic as well as synaptic NMDARs are present in hippocampal neurons (12), bath application of NMDA is expected to activate both. In an alternative approach for NMDAR activation, we treated neurons that had formed mature synapses (11–14 DIV) (13) with the NMDAR antagonist DL-2-amino-5-phosphonovaleric acid (APV) (200 μM) for 3 to 4 days and then removed APV for 15 min, thereby allowing glutamate released from presynaptic nerve terminals to activate synaptic NMDARs (14); it seems unlikely that significant amounts of glutamate could spill over from the synaptic cleft to activate extrasynaptic NMDARs without being diluted to an insignificant concentration in the bathing media. Compared with control neurons maintained in APV for an additional 15 min, removal of APV for 15 min significantly increased surface expression of endogenous GIRK1 and GIRK2 (P < 0.001) but not NR1 proteins (Fig. 1 NMDAR-Induced Surface Expression of GIRK Channels Requires Activation of PP1 but Not PP2B. NMDAR signaling may involve kinases or phosphatases (15). To test whether phosphorylation or dephosphorylation events are involved in NMDAR-induced GIRK surface expression, we treated neurons with 20 nM okadaic acid to inhibit protein phosphatase 2A (PP2A), 1 μM okadaic acid to inhibit PP1 and PP2A, or 10 μM cyclosporine A to inhibit protein phosphatase 2B (PP2B)/calcineurin (Fig. 2
We next investigated how NMDAR activation stimulates PP1 activity. Although PP2B is known to mediate NMDAR activation of PP1 by dephosphorylating the Thr-34/Thr-35 residues of dopamine- and cAMP-regulated phosphoprotein, 32-kDa (DARPP32)/Inhibitor-1 (I1), thereby relieving PP1 inhibition (16), we found that NMDAR activation did not induce dephosphorylation of DARPP32/I1 at Thr-34/Thr-35 (Fig. 2 NMDAR-Induced Surface Expression of GIRK Channels Requires the VL Internalization Motif of GIRK2. Given the presence of GIRK1 and GIRK2 in dendritic shafts and spines (9, 10) (Fig. 1
Surface expression of HA-GIRK1-GFP depends on its coassembly with GIRK2 to form heteromeric GIRK1/2 channels, because GIRK2 but not GIRK1 contains forward trafficking motifs (11). We therefore tested whether NMDAR activation increases surface expression of GIRK2-containing channels by regulating forward or endocytic trafficking of GIRK2 (11). Indeed, deletion or mutation of VL internalization motif (ΔN15, ΔN45, VL/AA) increased basal surface expression of GIRK2 in dendrites (P < 0.001) and occluded the NMDAR-induced increase of surface expression (Fig. 3 NMDAR-Induced GIRK Surface Expression Requires Rme1-Dependent Recycling of GIRK Channels to Plasma Membrane. Because NMDAR-induced surface expression of GIRK2 requires the VL internalization motif (Fig. 3 To test whether the regulation involves channel trafficking from recycling endosomes, we examined NMDAR-induced GIRK surface expression in the presence of primaquine, which acutely and selectively inhibits recycling but not endocytosis (19). Treatment with 60 μM primaquine not only blocked recycling of endogenous transferrin receptors (Fig. S5) but also abolished NMDAR-induced surface expression of endogenous GIRK2 proteins (Fig. 4
NMDAR Activation Induces PP1-Dependent Dephosphorylation of GIRK2 Ser-9 Near VL Internalization Motif. How might NMDAR-induced GIRK surface expression depend on channel delivery from recycling endosomes, VL internalization motif of GIRK2, and PP1 activity? Compared with the canonical dileucine internalization signal [D/E]xxxL[L/I] that mediates rapid internalization via the dileucine motif L[L/I] and targeting to late endosomes and lysosomes via an acidic amino acid residue [D/E] at the −4 position (21), the VL internalization signal of GIRK2 (SMTNVL) has a serine at the −4 position (Fig. 6
To test whether GIRK2 Ser-9 is phosphorylated in vivo, we generated a phosphorylation site-specific antibody against a peptide containing the first 17 aa of GIRK2, including a phosphorylated Ser-9 (Fig. S6A), and demonstrated its specificity (Fig. S6B). The resulting antibody detected a protein of 48 kDa in rat brain membrane homogenates, which comigrated with the GIRK2 proteins detected by anti-GIRK2 N-terminal antibody (Fig. S6C) and immunoprecipitated 9.9% ± 3.9% of total GIRK2 proteins from cultured hippocampal neurons (n = 4). Moreover, phosphorylation of GIRK2 Ser-9 was reduced to half by bath application of NMDA (P < 0.001) and synaptic NMDAR activation (P < 0.01; Fig. 5
Although both PP1 and PP2B can dephosphorylate GIRK2 Ser-9 in vitro (Fig. 5 NMDAR-Induced GIRK Surface Expression Requires Dephosphorylation of GIRK2 Ser-9, Which Promotes Channel Delivery from Recycling Endosomes. To test whether the phosphorylation state of Ser-9 near VL internalization motif affects GIRK surface expression, we mutated Ser-9 of GIRK2 to alanine (S9A) or aspartate (S9D) to mimic dephosphorylated or phosphorylated Ser-9, respectively. Whereas the single channel conductance was comparable between wild-type and Ser-9 mutant channels (Fig. S7 A and B), S9A mutant channels yielded ≈3-fold higher surface expression than wild-type and S9D mutant channels in HEK293T cells (P < 0.001; Fig. S7C). To test whether the phosphorylation state of Ser-9 modulates GIRK recycling, we performed channel endocytosis assay (22) (Fig. S8A) to follow the internalization of surface GIRK2 proteins (Fig. S8B) to endocytic compartments with or without prior treatment of primaquine to block recycling (19) (Fig. S8C) and quantified the amount of surface GIRK2 proteins that had been internalized and remained inside the cell over a period of 80 min (Fig. 6 In cultured hippocampal neurons, both wild-type GIRK2 and S9D mutant proteins showed punctate distribution in soma and dendrites, whereas S9A mutant proteins displayed more diffuse distribution in both proximal and distal dendrites as well as spines, consistent with its elevated basal surface expression (Fig. 6 Discussion Activity-Dependent Dephosphorylation and Trafficking of GIRK Channels. In this study we demonstrate that NMDAR activation in cultured hippocampal neurons increases surface expression of GIRK channels by stimulating PP1-dependent dephosphorylation of Ser-9 near the VL internalization motif of GIRK2. Ser-9 phosphorylation targets GIRK2-containing channels to lysosomes, whereas dephosphorylation of Ser-9 promotes Rme1-dependent traffic of these channels from recycling endosomes to plasma membrane, similar to the phosphorylation-dependent endocytic traffic regulation of T cell antigen receptors and CD4 coreceptor proteins (21). This Ser-9-containing recycling motif is unique to GIRK2 and is not found in other GIRK subunits. The level of basal phosphorylation at Ser-9 (≈10% of total GIRK2 proteins) is large enough to allow a 2-fold reduction of Ser-9 phosphorylation induced by NMDAR activation to increase surface expression of GIRK2 (from ≈18% to ≈36% total GIRK2 proteins) and GIRK1 (from ≈7% to ≈14% total GIRK1 proteins) if Ser-9 dephosphorylation of one GIRK2 subunit promotes recycling of GIRK2 homotetramers and GIRK1/2 heterotetramers to the plasma membrane. Given that newly synthesized membrane proteins, such as transferrin receptors and E-cadherin, have been shown to move from Golgi directly to recycling endosomes, which serve as a reserve pool for subsequent plasma membrane insertion (23, 24), it is possible that a similar reserve pool of GIRK2-containing channels in recycling endosomes could be subject to traffic regulation by NMDAR and PP1. We also discovered that NMDAR activation stimulates PP1 by decreasing phosphorylation of PP1 at Thr-320, a site for Cdk5 phosphorylation to inhibit PP1 (17), rather than PP2B-mediated dephosphorylation of PP1 inhibitor proteins DARPP32/I1, implicating PP1 but not PP2B in the signaling pathway. We speculate that, as reported in previous studies, NMDAR activation may induce calpain-mediated cleavage of the Cdk5 activator p35 to p25 (25), causing dissociation of Cdk5 from membrane (26). This could remove Cdk5 from the proximity of membrane-associated PP1 (16), resulting in reduction of Thr-320 phosphorylation and activation of PP1. In light of recent findings that the sorting nexin SNX27 regulates trafficking of GIRK subunits to the early endosome by associating with the C terminus of GIRK2C and GIRK3 (27), it will be important to elucidate how phosphorylation state of Ser-9 affects GIRK endocytic trafficking by identifying proteins that interact with GIRK2 in a Ser-9 phosphorylation-dependent manner. Physiologic Implications of NMDAR-Induced Increase in GIRK Surface Density. Activity-dependent K+ channel trafficking could influence neuronal excitability. For example, glutamate-induced neuronal activity in hippocampal neurons redistributes Kv2.1 on the somatic membrane and modifies the delayed rectifier Kv current (28). Neuronal activity also causes Kv4.2 internalization in spines and dendrites to reduce the A-type Kv current and regulate synaptic integration (29). Here we demonstrate that NMDAR activation increases surface density of GIRK channels in soma, dendrites, and some spines of hippocampal neurons within 15 min. Considering the distribution of adenosine A1 receptors (30, 31) and GABAB receptors (10, 32) in the spines and dendritic shafts of hippocampal neurons and the functional coupling of GIRK channels to these GPCRs (7), as well as basal activities of GIRK channels on dendrites (4), NMDAR-induced GIRK surface expression could rapidly reduce membrane excitability in dendrites and spines, shunt the excitatory synaptic inputs, regulate synaptic integration of excitatory inputs, and alter the neuron's response to inhibitory transmitters or modulators (5, 6, 33). Thus, NMDAR-induced GIRK surface expression may also modulate activity-dependent changes in synaptic strength (synaptic plasticity), such as long-term potentiation, a cellular correlate of learning and memory (15). Given the expected difference in traffic patterns of GIRK channels with different subunit composition (11), it is of interest to note that GIRK channels containing GIRK1 and GIRK4 move from thyroid-stimulating hormone-containing dense core vesicles to the plasma membrane upon vesicle fusion, likely providing feedback regulation of hormone secretion in the anterior pituitary lobe (34). Materials and Methods Details of materials and experimental methods are in SI Materials. The use and care of animals in this study follows the guideline of the Institutional Animal Care and Use Committee at University of California, San Francisco. Induction of Neuronal Activity in Primary Hippocampal Culture. Primary hippocampal cultures from 18-day embryonic rats were prepared as described previously (35). Neurons (14–17 DIV) were incubated with artificial cerebrospinal fluid (ACSF, pH 7.4, osmolarity 300; 10 mM Hepes-free acid, 145 mM NaCl, 2.5 mM KCl, 10 mM glucose, 1 mM MgCl2, 2 mM CaCl2, and 0.1 mM picrotoxin) for 20 min (control) or with modified ACSF containing 50 mM KCl for 20 min, or with ACSF containing 100 μM glutamate, or 100 μM NMDA/1 μM glycine/5 μM strychnine for 1 min at 37 °C, followed by ACSF for 20 min. Removal of APV to activate synaptic NMDARs was performed as described previously (14). Biotinylation Assay. Surface biotinylation and degradation were performed on cultured hippocampal neurons as described elsewhere (13). Neurons were treated with the indicated inhibitors 1 h before and during NMDAR activation. The surface/total density ratio of test samples was normalized to the ratio of control samples to obtain percentage control. Immunocytochemistry. Regulation of Ser-9 Phosphorylation of GIRK2 in Hippocampal Neurons. Anti-GIRK2-pSer9 antibody was raised against the synthetic peptide corresponding to amino acids 1–17 of GIRK2 with phosphoserine included at the Ser-9 (Covance) and affinity purified from the sera (Pierce). Immunoblot analysis with anti-GIRK2-pSer9 and N-terminal antibodies, anti-DARPP32 and pThr34 antibodies, or anti-PP1α and pThr320 antibodies (Cell Signaling) was performed on lysates of cultured hippocampal neurons. The extent of phosphorylation was quantified by calculating the phosphorylation/total protein density ratio of test samples and was normalized to the ratio of control samples to obtain percentage control. Statistical Analysis. All data are reported as mean ± SEM. Sample size n refers to the number of dishes analyzed in biotinylation and phosphorylation experiments, or the number of transfected cells processed in surface immunostaining, or channel endocytosis. ANOVA and post-ANOVA Tukey's multiple comparison tests were performed to test the statistical difference between the groups of 3 or more, whereas Student's t test or paired t test was performed for groups of 2 using Prism4 (GraphPad Software). Supporting Information
Acknowledgments. This work was supported a by National Institutes of Health National Research Service Award postdoctoral fellowship (to H.J.C.) and by National Institute of Mental Health Grant MH65334. L.Y.J. and Y.N.J. are Howard Hughes Medical Institute investigators. Footnotes The authors declare no conflict of interest. This article contains supporting information online at www.pnas.org/cgi/content/full/0811615106/DCSupplemental. References 1. Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev. 1998;50:723–760. [PubMed] 2. Mark MD, Herlitze S. G-protein mediated gating of inward-rectifier K+ channels. Eur J Biochem. 2000;267:5830–5836. [PubMed] 3. Takigawa T, Alzheimer C. G protein-activated inwardly rectifying K+ (GIRK) currents in dendrites of rat neocortical pyramidal cells. J Physiol. 1999;517(Pt 2):385–390. [PubMed] 4. Chen X, Johnston D. Constitutively active G-protein-gated inwardly rectifying K+ channels in dendrites of hippocampal CA1 pyramidal neurons. J Neurosci. 2005;25:3787–3792. [PubMed] 5. Takigawa T, Alzheimer C. Phasic and tonic attenuation of EPSPs by inward rectifier K+ channels in rat hippocampal pyramidal cells. J Physiol. 2002;539(Pt 1):67–75. [PubMed] 6. Takigawa T, Alzheimer C. Interplay between activation of GIRK current and deactivation of Ih modifies temporal integration of excitatory input in CA1 pyramidal cells. J Neurophysiol. 2003;89:2238–2244. [PubMed] 7. Luscher C, Jan LY, Stoffel M, Malenka RC, Nicoll RA. G protein-coupled inwardly rectifying K+ channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron. 1997;19:687–695. [PubMed] 8. Kobayashi T, Ikeda K. G protein-activated inwardly rectifying potassium channels as potential therapeutic targets. Curr Pharm Des. 2006;12:4513–4523. [PubMed] 9. Drake CT, Bausch SB, Milner TA, Chavkin C. GIRK1 immunoreactivity is present predominantly in dendrites, dendritic spines, and somata in the CA1 region of the hippocampus. Proc Natl Acad Sci USA. 1997;94:1007–1012. [PubMed] 10. Kulik A, et al. Compartment-dependent colocalization of Kir3.2-containing K+ channels and GABAB receptors in hippocampal pyramidal cells. J Neurosci. 2006;26:4289–4297. [PubMed] 11. Ma D, et al. Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron. 2002;33:715–729. [PubMed] 12. Rosenmund C, Feltz A, Westbrook GL. Synaptic NMDA receptor channels have a low open probability. J Neurosci. 1995;15:2788–2795. [PubMed] 13. Mammen AL, Huganir RL, O'Brien RJ. Redistribution and stabilization of cell surface glutamate receptors during synapse formation. J Neurosci. 1997;17:7351–7358. [PubMed] 14. Liao D, Zhang X, O'Brien R, Ehlers MD, Huganir RL. Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons. Nat Neurosci. 1999;2:37–43. [PubMed] 15. Lee HK. Synaptic plasticity and phosphorylation. Pharmacol Ther. 2006;112:810–832. [PubMed] 16. Munton RP, Vizi S, Mansuy IM. The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett. 2004;567:121–128. [PubMed] 17. Dohadwala M, et al. Phosphorylation and inactivation of protein phosphatase 1 by cyclin-dependent kinases. Proc Natl Acad Sci USA. 1994;91:6408–6412. [PubMed] 18. Chen L, et al. A glutamate residue at the C terminus regulates activity of inward rectifier K+ channels: Implication for Andersen's syndrome. Proc Natl Acad Sci USA. 2002;99:8430–8435. [PubMed] 19. van Weert AW, Geuze HJ, Groothuis B, Stoorvogel W. Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol. 2000;79:394–399. [PubMed] 20. Lin SX, Grant B, Hirsh D, Maxfield FR. Rme-1 regulates the distribution and function of the endocytic recycling compartment in mammalian cells. Nat Cell Biol. 2001;3:567–572. [PubMed] 21. Bonifacino JS, Traub LM. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem. 2003;72:395–447. [PubMed] 22. Hu K, Huang CS, Jan YN, Jan LY. ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C. Neuron. 2003;38:417–432. [PubMed] 23. Futter CE, Connolly CN, Cutler DF, Hopkins CR. Newly synthesized transferrin receptors can be detected in the endosome before they appear on the cell surface. J Biol Chem. 1995;270:10999–11003. [PubMed] 24. Lock JG, Stow JL. Rab11 in recycling endosomes regulates the sorting and basolateral transport of E-cadherin. Mol Biol Cell. 2005;16:1744–1755. [PubMed] 25. Kerokoski P, Suuronen T, Salminen A, Soininen H, Pirttila T. Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons. Neurosci Lett. 2004;368:181–185. [PubMed] 26. Patrick GN, et al. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 1999;402:615–622. [PubMed] 27. Lunn ML, et al. A unique sorting nexin regulates trafficking of potassium channels via a PDZ domain interaction. Nat Neurosci. 2007;10:1249–1259. [PubMed] 28. Misonou H, et al. Regulation of ion channel localization and phosphorylation by neuronal activity. Nat Neurosci. 2004;7:711–718. [PubMed] 29. Kim J, Jung SC, Clemens AM, Petralia RS, Hoffman DA. Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons. Neuron. 2007;54:933–947. [PubMed] 30. Ochiishi T, et al. Cellular localization of adenosine A1 receptors in rat forebrain: Immunohistochemical analysis using adenosine A1 receptor-specific monoclonal antibody. J Comp Neurol. 1999;411:301–316. [PubMed] 31. Rebola N, Pinheiro PC, Oliveira CR, Malva JO, Cunha RA. Subcellular localization of adenosine A(1) receptors in nerve terminals and synapses of the rat hippocampus. Brain Res. 2003;987:49–58. [PubMed] 32. Kulik A, et al. Subcellular localization of metabotropic GABA(B) receptor subunits GABA(B1a/b) and GABA(B2) in the rat hippocampus. J Neurosci. 2003;23:11026–11035. [PubMed] 33. Ehrengruber MU, et al. Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons. Proc Natl Acad Sci USA. 1997;94:7070–7075. [PubMed] 34. Morishige K, et al. Secretagogue-induced exocytosis recruits G protein-gated K+ channels to plasma membrane in endocrine cells. J Biol Chem. 1999;274:7969–7974. [PubMed] 35. Chung HJ, Jan YN, Jan LY. Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in the KCNQ2 and KCNQ3 C-terminal domains. Proc Natl Acad Sci USA. 2006;103:8870–8875. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Pharmacol Rev. 1998 Dec; 50(4):723-60.
[Pharmacol Rev. 1998]Eur J Biochem. 2000 Oct; 267(19):5830-6.
[Eur J Biochem. 2000]Pharmacol Rev. 1998 Dec; 50(4):723-60.
[Pharmacol Rev. 1998]J Physiol. 1999 Jun 1; 517 ( Pt 2)():385-90.
[J Physiol. 1999]J Neurosci. 2005 Apr 13; 25(15):3787-92.
[J Neurosci. 2005]J Physiol. 2002 Feb 15; 539(Pt 1):67-75.
[J Physiol. 2002]J Neurophysiol. 2003 Apr; 89(4):2238-44.
[J Neurophysiol. 2003]Proc Natl Acad Sci U S A. 1997 Feb 4; 94(3):1007-12.
[Proc Natl Acad Sci U S A. 1997]J Neurosci. 2006 Apr 19; 26(16):4289-97.
[J Neurosci. 2006]Proc Natl Acad Sci U S A. 1997 Feb 4; 94(3):1007-12.
[Proc Natl Acad Sci U S A. 1997]J Neurosci. 2006 Apr 19; 26(16):4289-97.
[J Neurosci. 2006]Neuron. 2002 Feb 28; 33(5):715-29.
[Neuron. 2002]J Neurosci. 1995 Apr; 15(4):2788-95.
[J Neurosci. 1995]J Neurosci. 1997 Oct 1; 17(19):7351-8.
[J Neurosci. 1997]Nat Neurosci. 1999 Jan; 2(1):37-43.
[Nat Neurosci. 1999]Pharmacol Ther. 2006 Dec; 112(3):810-32.
[Pharmacol Ther. 2006]FEBS Lett. 2004 Jun 1; 567(1):121-8.
[FEBS Lett. 2004]Proc Natl Acad Sci U S A. 1994 Jul 5; 91(14):6408-12.
[Proc Natl Acad Sci U S A. 1994]Pharmacol Ther. 2006 Dec; 112(3):810-32.
[Pharmacol Ther. 2006]Proc Natl Acad Sci U S A. 1997 Feb 4; 94(3):1007-12.
[Proc Natl Acad Sci U S A. 1997]J Neurosci. 2006 Apr 19; 26(16):4289-97.
[J Neurosci. 2006]Neuron. 2002 Feb 28; 33(5):715-29.
[Neuron. 2002]Proc Natl Acad Sci U S A. 2002 Jun 11; 99(12):8430-5.
[Proc Natl Acad Sci U S A. 2002]J Physiol. 1999 Jun 1; 517 ( Pt 2)():385-90.
[J Physiol. 1999]Neuron. 2002 Feb 28; 33(5):715-29.
[Neuron. 2002]Eur J Cell Biol. 2000 Jun; 79(6):394-9.
[Eur J Cell Biol. 2000]Nat Cell Biol. 2001 Jun; 3(6):567-72.
[Nat Cell Biol. 2001]Annu Rev Biochem. 2003; 72():395-447.
[Annu Rev Biochem. 2003]Neuron. 2003 May 8; 38(3):417-32.
[Neuron. 2003]Eur J Cell Biol. 2000 Jun; 79(6):394-9.
[Eur J Cell Biol. 2000]Pharmacol Rev. 1998 Dec; 50(4):723-60.
[Pharmacol Rev. 1998]Eur J Biochem. 2000 Oct; 267(19):5830-6.
[Eur J Biochem. 2000]J Physiol. 1999 Jun 1; 517 ( Pt 2)():385-90.
[J Physiol. 1999]J Neurosci. 2005 Apr 13; 25(15):3787-92.
[J Neurosci. 2005]J Physiol. 2002 Feb 15; 539(Pt 1):67-75.
[J Physiol. 2002]Annu Rev Biochem. 2003; 72():395-447.
[Annu Rev Biochem. 2003]J Biol Chem. 1995 May 5; 270(18):10999-1003.
[J Biol Chem. 1995]Mol Biol Cell. 2005 Apr; 16(4):1744-55.
[Mol Biol Cell. 2005]Proc Natl Acad Sci U S A. 1994 Jul 5; 91(14):6408-12.
[Proc Natl Acad Sci U S A. 1994]Neurosci Lett. 2004 Sep 23; 368(2):181-5.
[Neurosci Lett. 2004]Nature. 1999 Dec 9; 402(6762):615-22.
[Nature. 1999]FEBS Lett. 2004 Jun 1; 567(1):121-8.
[FEBS Lett. 2004]Nat Neurosci. 2007 Oct; 10(10):1249-59.
[Nat Neurosci. 2007]Nat Neurosci. 2004 Jul; 7(7):711-8.
[Nat Neurosci. 2004]Neuron. 2007 Jun 21; 54(6):933-47.
[Neuron. 2007]J Comp Neurol. 1999 Aug 23; 411(2):301-16.
[J Comp Neurol. 1999]Brain Res. 2003 Oct 10; 987(1):49-58.
[Brain Res. 2003]J Neurosci. 2006 Apr 19; 26(16):4289-97.
[J Neurosci. 2006]Proc Natl Acad Sci U S A. 2006 Jun 6; 103(23):8870-5.
[Proc Natl Acad Sci U S A. 2006]Nat Neurosci. 1999 Jan; 2(1):37-43.
[Nat Neurosci. 1999]J Neurosci. 1997 Oct 1; 17(19):7351-8.
[J Neurosci. 1997]Proc Natl Acad Sci U S A. 2006 Jun 6; 103(23):8870-5.
[Proc Natl Acad Sci U S A. 2006]Neuron. 2003 May 8; 38(3):417-32.
[Neuron. 2003]